Systemic-onset juvenile idiopathic arthritis: the changing life of a rare disease

被引:10
|
作者
Cimaz, Rolando [1 ]
Von Scheven, Annette [2 ,3 ]
Hofer, Michael [2 ,3 ]
机构
[1] AOU Meyer, I-50139 Florence, Italy
[2] CHU Vaudois, Lausanne, Switzerland
[3] HUG, Geneva, Switzerland
关键词
pediatric rheumatology; MACROPHAGE-ACTIVATION SYNDROME; RECEPTOR ANTAGONIST ANAKINRA; ADULT STILLS-DISEASE; RHEUMATOID-ARTHRITIS; IL-1; BLOCKADE; DOUBLE-BLIND; OPEN-LABEL; PHASE-II; INTERLEUKIN-18; EFFICACY;
D O I
10.4414/smw.2012.13582
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic-onset juvenile idiopathic arthritis (SoJIA), sometimes called Still's disease, is a systemic inflammatory disease classified within the spectrum of juvenile idiopathic arthritis (JIA). It is an orphan disease with often a chronic course and a major impact on the affected children and their families. This disorder is unique in terms of clinical manifestations, prognosis and response to conventional immunosuppressants. The objectives of this review are to describe SoJIA and emphasise the recent advances in the pathogenesis and treatment, which have transformed the care and the prognosis of this potentially life-threatening paediatric condition.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Systemic-onset juvenile idiopathic arthritis - Disease course and significance of early clinical and laboratory features
    Singh-Grewal, D
    Bayer, N
    Schneider, R
    Feldman, BM
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (07) : 1407 - 1407
  • [42] Seasonal onset of systemic-onset juvenile rheumatoid arthritis
    Feldman, BM
    Birdi, N
    Boone, JE
    Dent, PB
    Duffy, CM
    Ellsworth, JE
    Lang, BA
    Laxer, RM
    Lewkonia, RM
    Malleson, PN
    Oen, KG
    Paquin, JD
    Rosenberg, AM
    Schneider, R
    Silverman, ED
    JOURNAL OF PEDIATRICS, 1996, 129 (04): : 513 - 518
  • [43] Macrophage activation syndrome in 13 children with systemic-onset juvenile idiopathic arthritis
    Hua-Song Zeng
    Xiao-Yan Xiong
    Yan-Dan Wei
    Hong-Wei Wang
    Xiao-Ping Luo
    World Journal of Pediatrics, 2008, 4 : 97 - 101
  • [44] Tocilizumab-induced hypofibrinogenemia in patients with systemic-onset juvenile idiopathic arthritis
    Tingyan He
    Jiayun Ling
    Jun Yang
    Scientific Reports, 13
  • [45] IL-6 as a therapeutic target in systemic-onset juvenile idiopathic arthritis
    Yokota, S
    Miyamae, T
    Imagawa, T
    Mori, M
    ARTHRITIS RESEARCH & THERAPY, 2003, 5 (Suppl 3) : S22 - S23
  • [46] Tocilizumab-induced hypofibrinogenemia in patients with systemic-onset juvenile idiopathic arthritis
    He, Tingyan
    Ling, Jiayun
    Yang, Jun
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [47] The role of heme oxygenase-1 in systemic-onset juvenile idiopathic arthritis
    Takahashi, Akitaka
    Mori, Masaaki
    Naruto, Takuya
    Nakajima, Shoko
    Miyamae, Takako
    Imagawa, Tomoyuki
    Yokota, Shumpei
    MODERN RHEUMATOLOGY, 2009, 19 (03) : 302 - 308
  • [48] Is tocilizumab a good therapeutic option for RA and systemic-onset juvenile idiopathic arthritis?
    Cem Gabay
    Nature Clinical Practice Rheumatology, 2008, 4 : 572 - 573
  • [49] Remission of Refractory Systemic-Onset Juvenile Idiopathic Arthritis After Treatment With Siltuximab
    Leurs, Amelie
    Launay, David
    Terriou, Louis
    Hatron, Pierre-Yves
    Quartier, Pierre
    Hachulla, Eric
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 (04) : E40 - E42
  • [50] Development of germinoma during the treatment of systemic-onset juvenile idiopathic arthritis with infliximab
    Takezaki, Shunichiro
    Okura, Yuka
    Ichikawa, Mizuho
    Suzuki, Daisuke
    Ohshima, Junjiro
    Kaneda, Makoto
    Cho, Yuko
    Yamada, Masafumi
    Kawamura, Nobuaki
    Iguchi, Akihiro
    Kobayashi, Ichiro
    Ariga, Tadashi
    MODERN RHEUMATOLOGY, 2012, 22 (04) : 621 - 624